Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.41 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL28942725 | 0.99 | EGFR (0.46) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL28075000 | 0.95 | F7 (0.50) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL6810323 | 0.95 | EGFR (0.43) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL28247648 | 0.90 | F7 (0.52) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL9274696 | 0.89 | F7 (0.54) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL135916 | 0.89 | ALDH1A1 (0.54) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL2564207 | 0.89 | F7 (0.56) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL15699 | 0.89 | F7 (0.56) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL22748483 | 0.89 | F7 (0.56) | EGFRSRCKDRALDH1A1F7 | |
| Adenine SCHEMBL23859925 | 0.88 | F7 (0.55) | EGFRSRCKDRALDH1A1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118033103-A | Carbon dioxide detection reagent and/or kit | 北京安图生物工程有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-114354524-A | Stable liquid detection kit | 北京九强生物技术股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-111996234-A | Serum carbon dioxide detection kit and preparation method thereof | 安徽伊普诺康生物技术股份有限公司 | 2020-11-27 | — | — | CN | claimed |
| CN-111893162-A | Carbon dioxide enzyme method determination kit | 武汉生之源生物科技股份有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-111575339-A | 1, 5-anhydroglucitol enzymatic quantitative method and reagent therefor | 王学忠 | 2020-08-25 | — | — | CN | claimed |
| WO-2019022469-A1 | USE OF NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (NADPH) OR DERIVATIVE THEREOF AS BETA-LACTAMASE INHIBITOR | 전북대학교산학협력단 | 2019-01-31 | — | — | WO | claimed |
| US-8690857-B2 | Alleviate back pain with lactic acid inhibitors | ALEEVA MEDICAL INC. (US) | 2014-04-08 | — | — | US | claimed |
| CN-103601780-A | Synthetic method of 3-acetylpyridine adenine dinucleotide | BEIJING LEADMAN BIOCHEMISTRY CO LTD | 2014-02-26 | — | — | CN | claimed |
| US-20130071871-A1 | ENZYMATIC DETERMINATION OF LITHIUM IONS USING PHOSPHOGLUCOMUTASE | SPECIALTY ASSAYS, INC. (US) | 2013-03-21 | — | — | US | claimed |
| US-20120022425-A1 | Alleviate back pain with lactic acid inhibitors | YEUNG JEFFREY ERIC (US) | 2012-01-26 | — | — | US | claimed |
| WO-2009135035-A1 | ENZYMATIC DETERMINATION OF POTASSIUM IONS USING STABLE NAD(P)H ANALOGS. | SPECIALTY ASSAYS, INC. (US) | 2009-11-05 | — | — | WO | claimed |
| US-6974665-B2 | In situ screening to optimize variables in organic reactions | UNIVERSITY OF NEBRASKA (US) | 2005-12-13 | — | — | US | claimed |
| US-20030148257-A1 | In situ screening to optimize variables in organic reactions | UNIVERSITY OF NEBRASKA (US) | 2003-08-07 | — | — | US | claimed |
| WO-1993021330-A1 | HUMAN GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMINO-TRANSFERASE | ZYMOGENETICS, INC. (US) | 1993-10-28 | — | — | WO | claimed |
| CN-118033103-A | Carbon dioxide detection reagent and/or kit | 北京安图生物工程有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117165615-A | Method for improving synthesis capacity of 1, 5-pentanediamine from head by regulating intracellular PLP supply | 江南大学 | 2023-12-05 | — | — | CN | disclosed |
| US-11766435-B2 | N3-substituted iminopyrimidinones as antimalarial agents | MERCK SHARP & DOHME LLC (US) | 2023-09-26 | — | — | US | disclosed |
| US-5202426-A | Production of cyclic adenosin diphosphate ribose from nicotinamide adenine dinucleotide | MARINE BIOLOGICAL LABORATORY (US) | 1993-04-13 | — | — | US | disclosed |
| CN-1019817-B | Stable dinucleotides composition and method of making the same | ABBOTT LAB (US) | 1992-12-30 | — | — | CN | disclosed |
| CN-87100939-A | Stable dinucleotides based composition and method | — | 1987-11-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11766435-B2 | N3-substituted iminopyrimidinones as antimalarial agents | CTSL, ANPEP, PRSS1 | EGFR 4667/4885SRC 4095/4885KDR 2930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.